-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Remodulin in Ischemia Reperfusion Injury
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Remodulin in Ischemia Reperfusion Injury report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Remodulin in Ischemia Reperfusion Injury Drug Details: Treprostinil (Remodulin, Treprost)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AG-181 in Phenylketonuria (PKU)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AG-181 in Phenylketonuria (PKU) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. AG-181 in Phenylketonuria (PKU) Drug Details: AG-181 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Seralutinib in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Seralutinib in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Seralutinib in Pulmonary Arterial Hypertension Drug Details: Seralutinib is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – MRNA-3210 in Phenylketonuria (PKU)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - MRNA-3210 in Phenylketonuria (PKU) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. MRNA-3210 in Phenylketonuria (PKU) Drug Details: mRNA-3210 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANPA-0073 in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANPA-0073 in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANPA-0073 in Pulmonary Arterial Hypertension Drug Details: ANPA-0073 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ANPA-0073 in Idiopathic Pulmonary Fibrosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ANPA-0073 in Idiopathic Pulmonary Fibrosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ANPA-0073 in Idiopathic Pulmonary Fibrosis Drug Details: ANPA-0073 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sotatercept in Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sotatercept in Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sotatercept in Pulmonary Hypertension Drug Details: Sotatercept (Winrevair) is an antihypertensive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Treprostinil Palmitil in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Treprostinil Palmitil in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Treprostinil Palmitil in Pulmonary Arterial Hypertension Drug Details: Treprostinil...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dimethyl Fumarate DR in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Dimethyl Fumarate DR in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dimethyl Fumarate DR in Systemic Sclerosis (Scleroderma) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CAP-1002 in Pulmonary Arterial Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CAP-1002 in Pulmonary Arterial Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CAP-1002 in Pulmonary Arterial Hypertension Drug Details: CAP-1002 is under...